Vicarious Surgical RBOT
OTC RBOT
$0.05 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Vicarious Surgical (RBOT) Long-Term Investments (2020 - 2023)

Vicarious Surgical's (RBOT) quarterly Long-Term Investments came in at $50.0 million in Q2 2023, little changed quarter-over-quarter from $49.8 million in Q1 2023.

Analysis

Vicarious Surgical (RBOT) Long-Term Investments (2020 - 2023) Analysis & Trends

Vicarious Surgical (RBOT) has reported Long-Term Investments for 3 consecutive years, with $50.0 million the latest figure, recorded in Q2 2023.

  • On a quarterly basis, Long-Term Investments changed N/A year-over-year to $50.0 million in Q2 2023; TTM through Jun 2023 was $50.0 million, a N/A change from a year earlier, with the FY2020 full-year figure at $345.2 million, changed N/A from the prior year.
  • Long-Term Investments was $50.0 million for Q2 2023 at Vicarious Surgical, roughly flat from $49.8 million in the prior quarter.
  • Over five years, Long-Term Investments peaked at $345.3 million in Q2 2021 and troughed at $49.8 million in Q1 2023.
  • A 3-year average of $246.8 million and a median of $345.1 million in 2020 frame the typical range for Long-Term Investments.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 1.11 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 3.41 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn -
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn -
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 2.25 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 244.10 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn -
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn -
10 Vicarious Surgical 231,626.35 -14.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 49.98 Mn
Mar 31, 2023 49.77 Mn
Jun 30, 2021 345.27 Mn
Mar 31, 2021 345.26 Mn
Dec 31, 2020 345.19 Mn
Sep 30, 2020 345.09 Mn